Extracellular vesicles from human cardiovascular progenitors trigger a reparative immune response in infarcted hearts

Archive ouverte

Lima Correa, Bruna | El Harane, Nadia | Gomez, Ingrid | Rachid Hocine, Hocine | Vilar, José | Desgres, Manon | Bellamy, Valérie | Keirththana, Kamaleswaran | Guillas, Chloé | Perotto, Maria | Pidial, Laetitia | Alayrac, Paul | Tran, Thi | Tan, Sisareuth | Hamada, Thomas | Charron, Dominique | Brisson, Alain | Renault, Nisa | Al-Daccak, Reem | Menasché, Philippe | Silvestre, Jean-Sébastien

Edité par CCSD ; Oxford University Press (OUP) -

International audience. The cardioprotective effects of human induced pluripotent stem cell-derived cardiovascular progenitor cells (CPC) are largely mediated by the paracrine release of extracellular vesicles (EV). We aimed to assess the immunological behaviour of EV-CPC, which is a prerequisite for their clinical translation. Flow cytometry demonstrated that EV-CPC expressed very low levels of immune relevant molecules including HLA Class I, CD80, CD274 (PD-L1), and CD275 (ICOS-L); and moderate levels of ligands of the natural killer (NK) cell activating receptor, NKG2D. In mixed lymphocyte reactions, EV-CPC neither induced nor modulated adaptive allogeneic T cell immune responses. They also failed to induce NK cell degranulation, even at high concentrations. These in vitro effects were confirmed in vivo as repeated injections of EV-CPC did not stimulate production of immunoglobulins or affect the interferon (IFN)-γ responses from primed splenocytes. In a mouse model of chronic heart failure, intra-myocardial injections of EV-CPC, 3 weeks after myocardial infarction, decreased both the number of cardiac pro-inflammatory Ly6Chigh monocytes and circulating levels of pro-inflammatory cytokines (IL-1α, TNF-α, and IFN-γ). In

Suggestions

Du même auteur

Therapeutic potential of extracellular vesicles derived from cardiac progenitor cells in rodent models of chemotherapy-induced cardiomyopathy

Archive ouverte | Desgres, Manon | CCSD

International audience. Background Current treatments of chemotherapy-induced cardiomyopathy (CCM) are of limited efficacy. We assessed whether repeated intravenous injections of human extracellular vesicles from ca...

Biomaterial-embedded extracellular vesicles improve recovery of the dysfunctional myocardium

Archive ouverte | Pezzana, Chloé | CCSD

International audience

In vitro controlled release of extracellular vesicles for cardiac repair from poly(glycerol sebacate) acrylate-based polymers

Archive ouverte | Hamada, Thomas | CCSD

International audience. Cell therapy to restore cardiac function in chronic heart failure has been extensively studied. However, its therapeutic value is limited due to poor cell engraftment and survival and the the...

Chargement des enrichissements...